Search Results 651-660 of 15425 for Aspergillosis

1. Antimicrobial Stewardship - Overview - Mayo Clinic

   Learn about the proper use of medicines used to treat infections caused by bacteria, fungi and viruses, an area of medicine called antimicrobial ...

2. DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) - Mayo Clinic

   The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.

3. Publications - Teresa A. Seville, M.D. - Mayo Clinic

   Impact of Perioperative Prophylaxis With Enterococcus Activity on Risk of Surgical-Site Infection After Pancreas Transplantation. Transplant Direct. 2023 Jul; 9 ...

4. Clinical trials - Gastroenterology and Hepatology

   The purpose of this study is to demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) learning health system approach that enables patients ...

5. Impact of Neoadjuvant Chemotherapy on the Peripheral Blood Immune Phenotype in Operable Breast Cancer, the ENHANCE Study - Mayo Clinic

   About this study. The purposes of this study are to evaluate whether pre-NAC peripheral blood immune phenotypes (defined by mass cytometry) are associated ...

6. A Dose-Ranging Study to Evaluate the Effectiveness and Safety of Topical Rapamycin Cream for Facial Angiofibroma Associated With Tuberous Sclerosis Complex - Mayo Clinic

   The purose of this study is to compare the safety and effectiveness of two different strengths of Rapamycin cream, topical and placebo over 26 weeks in the ...

7. Patient Stories - Cornelius A. Thiels, D.O., M.B.A. - Mayo Clinic

   Cornelius A. Thiels, D.O., M.B.A. · Hepatobiliary and Pancreas Surgeon · Surgical Oncologist.

8. Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/ ...

9. A Study to Evaluate MRTX849 in Patients with Advanced Solid Tumors with KRAS G12C Mutation - Mayo Clinic

   The purpose of this study is to characterize the safety and tolerability of MRTX849 in patients having advanced solid tumor malignancies with KRAS G12C mutation ...

10. News - Cornelius A. Thiels, D.O., M.B.A. - Mayo Clinic

    Cornelius A. Thiels, D.O., M.B.A. · Hepatobiliary and Pancreas Surgeon · Surgical Oncologist.